tiprankstipranks
Moleculin Biotech (MBRX)
NASDAQ:MBRX
Holding MBRX?
Track your performance easily

Moleculin Biotech (MBRX) Financial Statements

1,371 Followers

Moleculin Biotech Financial Overview

Moleculin Biotech's market cap is currently ―. The company's EPS TTM is $-11.691; its P/E ratio is -0.24; Moleculin Biotech is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-1.26. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 12.00K$ 12.00K---
Gross Profit$ 12.00K$ 12.00K---
EBIT$ -10.59M$ -4.32M$ 8.38M$ -8.92M$ -5.95M
EBITDA$ -10.56M$ -4.29M$ 8.42M$ -8.88M$ -5.92M
Net Income Common Stockholders$ -10.59M$ -4.32M$ -4.97M$ -10.27M$ -5.61M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.40M$ 10.85M$ 16.82M$ 23.55M$ 24.58M
Total Assets$ 23.39M$ 25.57M$ 30.84M$ 38.22M$ 39.52M
Total Debt$ 390.00K$ 420.00K$ 450.00K$ 474.00K$ 496.00K
Net Debt$ -9.02M$ -10.43M$ -16.37M$ -23.08M$ -24.08M
Total Liabilities$ 15.91M$ 7.87M$ 9.26M$ 12.14M$ 4.38M
Stockholders Equity$ 7.48M$ 17.70M$ 21.59M$ 26.07M$ 35.14M
Cash Flow-
Free Cash Flow$ -6.11M$ -5.96M$ -6.72M$ -5.49M$ -7.58M
Operating Cash Flow$ -6.11M$ -5.95M$ -6.72M$ -5.41M$ -7.55M
Investing Cash Flow-$ -13.00K-$ -81.00K$ -28.00K
Financing Cash Flow$ 4.66M$ -25.00K-$ 4.46M$ -4.00K
Currency in USD

Moleculin Biotech Earnings and Revenue History

Moleculin Biotech Debt to Assets

Moleculin Biotech Cash Flow

Moleculin Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis